Search for “AI in healthcare ROI” and most of what comes back is a vendor’s own case study, written by the company selling the tool, measuring the outcome the company chose to measure. That is not useless information, but it is not independent verification either.
This page does something different. It pulls together the AI in healthcare ROI case studies that came from independent researchers, peer reviewed journals, and industry benchmark studies that were not commissioned by the vendor whose product they evaluated, and it separates those from the vendor-reported numbers, labeling each clearly. Where the independent data and the vendor claims disagree, both are shown. No sponsored placements informed any part of this page.
Quick Facts
- The largest independent study of AI medical scribes, an 8,581-clinician JAMA study across five US academic medical centers, found scribe adopters saved 13.4 fewer minutes on the EHR and delivered 0.49 more visits per week, though only 21 percent of clinicians studied had actually adopted the tool
- A separate, single-site UCSF study of 1,565 physicians, published open access in JAMA Network Open, found scribe adopters generated 1.81 additional RVUs per week, a 5.8 percent increase worth roughly $3,044 in additional annual revenue per physician, with no increase in claim denials
- A separate UCLA randomized controlled trial of Microsoft DAX and Nabla found time savings of just 5 and 23 seconds per note, a reminder that scribe ROI varies sharply by vendor and specialty
- Only 15 percent of healthcare organizations using AI in revenue cycle management report positive ROI, despite 63 percent adoption, according to an HFMA and FinThrive poll of 101 healthcare organizations
- Canada’s largest AI scribe evaluation to date, an OntarioMD study of 152 family doctors and nurse practitioners, found 70 to 90 percent less time spent on paperwork and 3 to 4 hours saved per week, under PHIPA-compliant data handling
AI in Healthcare ROI: What the Case Studies Actually Show
| Use case | Independent finding | Vendor claim (if different) | Verdict |
|---|---|---|---|
| Ambient AI scribes (financial) | +1.81 RVUs/week (+5.8%), about $3,044 additional annual revenue per physician, no rise in denials (JAMA Netw Open, single-site UCSF, 1,565 physicians) | Some vendors imply larger, faster gains | Real but modest, and from one health system so far |
| Ambient AI scribes (time and visit volume) | 13.4 fewer EHR minutes/day, 16.0 fewer documentation minutes/day, +0.49 visits/week (JAMA, 8,581 clinicians, 5 sites); as little as 5 to 23 seconds saved per note in one RCT (NEJM AI) | “Hours saved daily” marketing claims | Highly variable by vendor and specialty |
| Ambient AI scribes (burnout) | Reduced burnout and after hours charting in multiple JAMA Network Open studies | Matches vendor framing | Strongest, most consistent evidence of any use case here |
| Ambient AI scribes (Canada) | 70 to 90% less documentation time, 3 to 4 hours saved/week (OntarioMD, 152 family doctors/NPs, PHIPA-compliant) | Similar time-savings claims from Canadian vendors | Real, largest Canadian evaluation to date, though smaller and shorter than the US JAMA studies |
| Revenue cycle management (RCM), industry wide | Only 15% report positive ROI despite 63% adoption (HFMA/FinThrive poll, 101 organizations) | Individual vendors report 200% plus ROI at specific sites | Success stories exist, but are not typical |
| RCM, named case study | 50% fewer discharged-not-final-billed cases, 40%+ coder productivity gain (Auburn Community Hospital, via AHA) | N/A, hospital-reported over a decade | Real, but a decade-long, multi-tool transformation, not a quick win |
| OR scheduling AI | Not independently audited | Fourfold ROI in 100 days, 61 added surgical cases (Qventus, via Healthcare IT News) | Vendor-reported, treat as directional only |
Ambient AI Scribes and Clinical Documentation: The Most Rigorously Tested ROI Case
Clinical documentation is the healthcare AI use case with the most independent, peer reviewed evidence behind it, largely because Harvard, UCSF, Yale, and several other academic medical centers have spent the past three years actually measuring it, rather than taking vendor word for it.
The single largest study is a multisite JAMA study led by Dr. Lisa Rotenstein, published April 1, 2026 and freely available in full through PubMed Central, covering 8,581 clinicians across five major US health systems, Mass General Brigham, Emory Healthcare, UC San Francisco, UC Davis, and Yale New Haven Health. Only 21 percent of the clinicians studied, 1,809 of them, had actually adopted an AI scribe. The findings were not a marketing win across the board. Adopters saved 13.4 fewer minutes of total EHR time and 16.0 fewer minutes of documentation time per eight hours of scheduled patient care, and delivered 0.49 additional visits per week. Time spent on the EHR outside scheduled hours did not change significantly, and the benefits were not evenly distributed: they were greatest for primary care specialists, advanced practice clinicians, female clinicians, and clinicians who used the scribe in half or more of their visits. That is a real, measured number, not a vendor projection, and it is also modest, not transformative.
A companion question, financial productivity rather than time, was answered by a separate, single-site study. Holmgren et al., published in JAMA Network Open and freely available under an open access license, examined nearly 1.2 million ambulatory encounters across 1,565 physicians at UCSF Health, of whom 698 had adopted an AI scribe. Adopters generated 1.81 additional RVUs per week, a 5.8 percent increase worth roughly $3,044 in additional annual revenue per physician, alongside a 2.8 percent increase in weekly encounters and no increase in claim denials. The study’s own authors caution that this is single-site data from early, voluntary adopters, and call for further research to confirm whether the RVU increase reflects genuinely more clinical work or simply improved coding capture.
A separate, smaller but more tightly controlled study makes the “it depends on the vendor” point even more clearly. A UCLA randomized controlled trial published in NEJM AI, covering 238 physicians across 14 specialties, tested Microsoft DAX and Nabla head to head. Nabla reduced time per note by about 23 seconds relative to control, and DAX’s 5 second reduction was not statistically significant. Both tools showed potential improvements in burnout and task load even where time savings barely moved, which lines up with a broader pattern in this research: ambient scribes have their strongest, most consistent evidence on clinician wellbeing, not on the clock.
North of the border, the largest Canadian evaluation to date tells a similar story of real, meaningful, if less rigorously controlled benefit. OntarioMD, a subsidiary of the Ontario Medical Association, ran a three month evaluation with the eHealth Centre of Excellence and Women’s College Hospital’s Institute for Health System Solutions and Virtual Care, testing AI scribes with 152 family doctors and nurse practitioners. Participants reported spending 70 to 90 percent less time on documentation and saved 3 to 4 hours per week on administrative tasks, with 83 percent saying they would keep using an AI scribe long term. The study explicitly notes that AI scribes are used only with patient consent and that data handling stays compliant with Ontario’s Personal Health Information Protection Act. Unlike the JAMA studies, this was a single evaluation without a matched non-adopter comparison group, so it sits closer to the OntarioMD/AHA case study tier of evidence than the peer reviewed US research above it.
Real world deployment data backs the general pattern up further. The Permanente Medical Group rolled out ambient AI scribes to roughly 10,000 physicians and staff starting in October 2023, and its own published follow-up reports more than 15,700 hours of documentation time saved in a single year, tracked through the American Medical Association. That figure is health system self-reported rather than independently audited, but it is consistent in direction with the JAMA multisite data above.
Independent third party validation exists too. KLAS Research, an independent healthcare technology research firm with no product to sell, found that St. Luke’s Health System’s enterprise deployment of Ambience Healthcare’s platform generated roughly $13,049 in additional annual revenue per clinician, driven by improved documentation and coding accuracy. The full KLAS report itself sits behind a login, so this figure is reported here via Fierce Healthcare’s independent coverage of it, not the vendor’s own page. Fierce Healthcare separately reported that Rush, McLeod Health, and FMOL Health saw revenue gains from Suki’s AI scribe, per the same KLAS validation series, McLeod specifically seeing a $1,004 per provider monthly gain tied to a shift toward higher, more accurate E/M coding levels. These are health system results validated by an independent research firm, worth more weight than a vendor’s own case study page, but still short of a randomized trial.
AI in Revenue Cycle Management: Real Gains, But Not the Norm Yet
Revenue cycle management is where the gap between AI hype and AI reality is widest right now, and the data is honest about that gap in a way most vendor content is not.
Start with the aggregate picture. An HFMA and FinThrive poll of 101 healthcare organizations found that 63 percent currently use AI or automation in the revenue cycle, yet only 15 percent report positive ROI, with 38 percent still laying groundwork or running pilots. A separate Experian Health 2025 State of Claims survey found denials, arguably the highest value use case, are also the least automated: just 14 percent of providers use AI specifically for denial reduction, despite 41 percent of providers now seeing denial rates above 10 percent. That is a very different picture from the confident “AI pays for itself” framing common in RCM vendor marketing.
That does not mean real wins do not exist. Auburn Community Hospital, an independent 99-bed rural access hospital in New York, is a genuine, named, multi-year case documented by the American Hospital Association. After roughly a decade of layering in RPA, natural language processing, and machine learning across its revenue cycle, the hospital reported a 50 percent reduction in discharged-not-final-billed cases, a more than 40 percent increase in coder productivity, and a 4.6 percent rise in case mix index that it credits to AI. This is a real, credible result, but it took nearly ten years of sustained investment, not a single tool deployment, which is a very different timeline than most RCM vendor pitches imply.
A faster-looking result comes from West Tennessee Healthcare’s use of Qventus’s AI scheduling software for operating room utilization, reported by Healthcare IT News: a 9 percent increase in orthopedic case volume and 61 additional surgical cases within the first 100 days, which the vendor’s own announcement described as a fourfold return on investment. This figure comes directly from Qventus’s announcement rather than an independent audit, and it should be read that way, a real deployment with a genuinely fast payback window on paper, but a vendor-reported number rather than a third-party verified one.
What This Means If You Are Evaluating an AI Vendor’s ROI Claim
Three patterns hold up across every case study in this roundup, and they are useful as a checklist against any vendor pitch.
First, financial ROI claims and clinician experience claims are not the same evidence, and they do not always move together. The JAMA scribe study found modest financial upside alongside consistently stronger burnout reduction. If a vendor leads only with a dollar figure, ask what happened to documentation time and clinician satisfaction separately, since a product that is good for one is not automatically good for the other.
Second, the timeline matters as much as the number. Auburn Community Hospital’s results took most of a decade. Qventus’s OR scheduling result is a 100 day snapshot. Both can be true and real, but comparing them as if they represent the same kind of investment is misleading, and it is worth asking any vendor directly how long their showcased customer had the tool running before the number was measured.
Third, industry wide benchmark data, like the 15 percent RCM ROI realization rate, is the most useful sanity check available precisely because no single vendor commissioned it. A vendor’s best customer case study is not a representative sample. An aggregated, multi-source benchmark comes closer to one.
FAQ
Is AI actually delivering ROI in healthcare, or is it mostly hype?
Both are true at once, depending on the use case. Ambient clinical documentation has real, independently measured financial and wellbeing gains, though modest ones. Revenue cycle management AI has genuine standout cases but only a 15 percent industry-wide positive ROI rate, according to an HFMA and FinThrive poll, so treat any single RCM success story as the exception rather than the expectation.
Which AI healthcare use case has the strongest independent ROI evidence?
Ambient AI scribes for clinical documentation, mainly because they have been studied in large, multisite, peer reviewed research rather than vendor case studies alone. The JAMA multisite study is the most rigorous evidence available on time and visit volume, and the companion JAMA Network Open study provides the strongest financial evidence, though from a single site so far. The burnout reduction evidence behind scribes is even more consistent than either.
Why do vendor ROI numbers sometimes look bigger than independent research?
Vendor case studies typically showcase their best-performing customer, over a timeframe and metric the vendor chooses, without a control group. Independent studies like the JAMA scribe research or the RCM benchmark aggregation measure across many organizations and often include a comparison group, which is why the numbers usually come in lower and more variable than a single vendor’s headline claim.
How long does it typically take to see ROI from healthcare AI?
It varies enormously by use case. Some scheduling and documentation deployments show measurable results within 100 days, per case studies like West Tennessee Healthcare’s OR scheduling rollout, while deeper, system-wide revenue cycle transformations, like Auburn Community Hospital’s, took closer to a decade to reach their full reported results.
0 Comments